Display options
Share it on

Adv Hematol. 2018 Jun 06;2018:5356245. doi: 10.1155/2018/5356245. eCollection 2018.

Frequency of Red Blood Cell Alloimmunization in Patients with Sickle Cell Disease in Palestine.

Advances in hematology

Fekri Samarah, Mahmoud A Srour, Dirgham Yaseen, Kamal Dumaidi

Affiliations

  1. Department of Medical Technology, Faculty of Allied Health Sciences, Arab American University in Jenin, State of Palestine.
  2. Department of Biology and Biochemistry, Faculty of Science, Birzeit University, Birzeit, State of Palestine.
  3. Rafidia Governmental Hospital, Ministry of Health, Nablus, State of Palestine.

PMID: 29977298 PMCID: PMC6011130 DOI: 10.1155/2018/5356245

Abstract

BACKGROUND: Transfusion of red blood cells (RBC) is an essential therapeutic tool in sickle cell disease (SCD). Repeated RBC transfusions can cause alloimmunization which causes difficulty in cross-matching and finding compatible blood for transfusions. This study aimed to investigate the frequency of RBC alloimmunization and related risk factors among Palestinian SCD patients.

MATERIALS AND METHODS: A multicenter cross-sectional study on 116 previously transfused SCD patients from three centers in West Bank, Palestine. Demographic, medical data and history of transfusion were recorded. Blood samples were collected from transfused consenting SCD patients. Gel card method was used for antibody screening and identification. In all patients, autocontrol and direct antiglobulin (DAT) test were performed using polyspecific (anti-IgG + C3d) anti-human globulin (AHG) gel cards for the detection of autoantibodies.

RESULTS: Of the SCD patients, 62 (53.4%) patients were HbSS and 54 (46.6%) patients were sickle

CONCLUSIONS: RBC alloimmunization rate among Palestinian SCD patients is low compared to neighboring countries and countries all over the world but still warrants more attention. Phenotyping of donors/recipients' RBC for Rh antigens and K

References

  1. Transfusion. 2002 Jun;42(6):684-90 - PubMed
  2. Bull World Health Organ. 2001;79(8):704-12 - PubMed
  3. Ethn Dis. 2010 Spring;20(2):136-41 - PubMed
  4. Hemoglobin. 2005;29(2):119-32 - PubMed
  5. Br J Haematol. 2001 Jun;113(3):661-5 - PubMed
  6. Transfusion. 1998 Nov-Dec;38(11-12):1015-21 - PubMed
  7. Blood. 2008 Sep 15;112(6):2546-53 - PubMed
  8. Blood. 2013 Aug 8;122(6):1062-71 - PubMed
  9. Clin Chem. 1974 Sep;20(9):1111-5 - PubMed
  10. Transfus Apher Sci. 2012 Dec;47(3):253-7 - PubMed
  11. N Engl J Med. 1990 Jun 7;322(23):1617-21 - PubMed
  12. Hematol Oncol Clin North Am. 2005 Oct;19(5):803-26, v-vi - PubMed
  13. Transfusion. 2002 Jan;42(1):37-43 - PubMed
  14. Am J Hematol. 2015 Aug;90(8):691-5 - PubMed
  15. Br J Haematol. 1988 Dec;70(4):455-8 - PubMed
  16. Br J Haematol. 1999 Jan;104(1):189-94 - PubMed
  17. JAMA. 2005 Apr 6;293(13):1653-62 - PubMed
  18. East Mediterr Health J. 2007 Sep-Oct;13(5):1181-9 - PubMed
  19. Transfus Med Rev. 2007 Apr;21(2):118-33 - PubMed
  20. East Afr J Public Health. 2014;11(2):775-780 - PubMed
  21. Lancet. 2004 Oct 9-15;364(9442):1343-60 - PubMed
  22. Mediterr J Hematol Infect Dis. 2017 Feb 15;9(1):e2017013 - PubMed
  23. Transfusion. 2015 Jan;55(1):36-44 - PubMed
  24. Transfusion. 2010 Jan;50(1):20-5 - PubMed
  25. Transfusion. 2009 Aug;49(8):1649-54 - PubMed
  26. Transfusion. 2017 Nov;57(11):2738-2746 - PubMed
  27. Blood. 1990 Oct 1;76(7):1431-7 - PubMed
  28. N Engl J Med. 1994 Jun 9;330(23):1639-44 - PubMed
  29. Braz J Med Biol Res. 2005 May;38(5):675-82 - PubMed
  30. Br J Haematol. 2017 May;177(4):641-647 - PubMed
  31. Blood. 2000 Nov 15;96(10):3369-73 - PubMed
  32. Biomark Res. 2015 Oct 13;3:26 - PubMed
  33. Transfusion. 1986 May-Jun;26(3):249-52 - PubMed
  34. Transfusion. 2018 Mar 23;:null - PubMed
  35. Hemoglobin. 2009;33(2):143-9 - PubMed
  36. Transfusion. 2006 Feb;46(2):250-6 - PubMed

Publication Types